intellectual property
Patent and know-how licensing: Going beyond the textbooks
December 16 by Charlotte TillettCharlotte Tillett, Partner at Stevens & Bolton LLP, discusses the key concerns of practitioners working with patents and know-how licenses
Less Risk, More Reward in IP
August 03 by Pharmaceuticals & Biotechnology EditorRead this paper to explore the drivers shaping the re-evaluation of IP in the research and development sector and the technical features that make a platform like E-WorkBook a particularly suitable...
Intellectual Property in the Global Marketplace: An Industry Investigation - 2014
August 07 by Pharmaceuticals & Biotechnology Editor89.7% of professionals in industry believe that intellectual property is and will be significant for them in 2014. In April and May 2014, we conducted Global Patent 2014 Survey. We surveyed&nbs...
Hands Off my Data: How to Protect Sensitive Information in the Biotech Industry
August 16 by Pharmaceuticals & Biotechnology EditorIntellectual property is the life sciences industry’s most important asset, because it forms the basis of product approvals and of cooperation, licensing and due diligence negotiations. That i...
Record Patent Filings “Encouraging News” for UK Business
March 07 by Pharma IQ News- Comment from Intellectual Property Specialists Marks & Clerk on 2012 patent filing statistics released by European Patent Office - Statistics from the Annual Report of European Patent Office...
Clinical Research “Likely to Return to the UK” Following Change in Patent Law
February 26 by Cold Chain IQ NewsComment from Intellectual Property specialists Marks & Clerk on the Government decision to exempt clinical and field trials from patent infringement - The UK Government has today announced pla...
Schutz sensibler Informationen in der Life Sciences Branche
January 12 by Pharmaceuticals & Biotechnology EditorThis whitepaper from Brainloop is an excellent reading companion to their Intellectual Property Protection Webinar. As any Out-licensing project manager will testify, protecting your intellectual...
Intellectual Property Protection Solutions for Pharma and Biotech - Part 2
November 10 by Pharma IQIn part one of our Brainloop interview we introduced BrigitteEhret, Director at Brainloop who explained some of the questions pharma professionals have about IP protection when partnerships demand d...
Don’t Lose Your Intellectual Property
October 15 by Andrea CharlesIn this Pharma IQ podcast David Topping, Vice President Global Marketing, Brainloop, and Andrea Charles from Pharma IQ, discuss what is out-licensing and the steps companies need to take to pro...
Ensuring Information Protection in the Electronic Communication Age
October 15 by Amber ScorahIn today's age of electronic communication, the ability to properly protect, monitor and disseminate information being transferred becomes more difficult. In this podcast, Joseph Mariano, a Reco...
Intellectual Property Protection Solutions for Pharma and Biotech
October 09 by Pharma IQIntellectual property is the life science industry’s most important capital. It forms the basis of a product’s market authorization, as well as of successful partnership, license and due...
Out-Licensing and Beyond - Secure Document based processes for the Life Sciences Industry
September 26 by Pharmaceuticals & Biotechnology EditorAlthough the business process of “Out-Licensing” is broadly agreed and understood, the way in which different companies go about implementing the process is widely varied. This variation...